CR20160054A - THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE - Google Patents

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

Info

Publication number
CR20160054A
CR20160054A CR20160054A CR20160054A CR20160054A CR 20160054 A CR20160054 A CR 20160054A CR 20160054 A CR20160054 A CR 20160054A CR 20160054 A CR20160054 A CR 20160054A CR 20160054 A CR20160054 A CR 20160054A
Authority
CR
Costa Rica
Prior art keywords
methods
active compounds
therapeutically active
treating cancer
idh2
Prior art date
Application number
CR20160054A
Other languages
Spanish (es)
Inventor
Samuel V Agresta
Chong-Hui Gu
David Schenkein
Hua Yang
Liting Guo
Zhen Tang
Jianming Wang
Yanfeng Zhang
Yan Zhou
Original Assignee
Agios Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2014/049469 external-priority patent/WO2015017821A2/en
Application filed by Agios Pharmaceuticals Inc filed Critical Agios Pharmaceuticals Inc
Publication of CR20160054A publication Critical patent/CR20160054A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se proporcionan compuestos inhibidores de isocitrato deshidrogenasa 2 (IDH2) útiles para tratar cáncer y métodos para tratar cáncer, que comprenden administrar a un sujeto en necesidad del mismo, un compuesto descrito en la presente.Isocitrate dehydrogenase 2 (IDH2) inhibitor compounds useful for treating cancer and methods for treating cancer are provided, comprising administering to a subject in need thereof, a compound described herein.

CR20160054A 2013-08-02 2016-01-29 THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE CR20160054A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361861884P 2013-08-02 2013-08-02
PCT/US2014/049469 WO2015017821A2 (en) 2013-08-02 2014-08-01 Therapeutically active compounds and their methods of use

Publications (1)

Publication Number Publication Date
CR20160054A true CR20160054A (en) 2016-06-13

Family

ID=56131704

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20160054A CR20160054A (en) 2013-08-02 2016-01-29 THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

Country Status (2)

Country Link
AR (1) AR097237A1 (en)
CR (1) CR20160054A (en)

Also Published As

Publication number Publication date
AR097237A1 (en) 2016-03-02

Similar Documents

Publication Publication Date Title
ECSP24031979A (en) THERAPEUTIC ACTIVE COMPOUNDS AND THEIR METHODS OF USE
ECSP14012726A (en) THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
CR20140388A (en) THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
MX2020011104A (en) PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE.
BR112016002287A2 (en) therapeutically active compounds and their methods of use
MX2016004580A (en) USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA.
MX367389B (en) COMPOUNDS AND THEIR METHODS OF USE.
MX2016015434A (en) Pharmaceutical combinations for treating cancer.
BR112015005369A2 (en) usp30 inhibitors and methods for their use
HK1223924A1 (en) Therapeutically active compounds and their methods of use
MX2016015437A (en) COMBINATION THAT INCLUDES A GLUCOCORTICOID AND EDO-S101.
CL2019002340A1 (en) Compositions and methods for promoting hair growth with mpc1 inhibitors.
MX2019010707A (en) Methods of treating and/or preventing actinic keratosis.
MX2017011018A (en) Inhibition of olig2 activity.
AR095015A1 (en) AZETIDINYLOXYPHENYLPIRROLIDINE COMPOUNDS
CR20160054A (en) THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
DOP2014000221A (en) METHODS TO TREAT CANCER USING PI3K INHIBITOR AND MEK INHIBITOR
BR112015025101A2 (en) antitumor composition comprising a pi3kbeta-selective inhibitor and a pi3kalfa-selective inhibitor